Actively Recruiting
A Study to Understand Long-Term Treatments and Biomarkers in Myasthenia Gravis Patients in China
Led by Peking Union Medical College Hospital · Updated on 2024-01-12
202
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating long-term treatment strategies and biomarkers for myasthenia gravis MG in this prospective cohort study. The study focuses on whether maintaining low-dose oral steroids can reduce the recurrence rate of MG and aims to identify biomarkers that may predict disease progression and prognosis. Participants are patients with well-controlled MG. Participants are divided into two groups based on their preferences and medical considerations such as other health conditions. One group continues low-dose oral steroid therapy while the other group withdraws from all immunosuppressants. These groups will be monitored over a long-term period with regular assessments. During the study, participants will undergo follow-up evaluations to monitor MG relapses within two years after recruitment. Researchers will assess the timing of relapses, changes in MG assessment scales, and any adverse events related to steroid use. This ongoing monitoring aims to better understand treatment outcomes and disease progression in MG patients.
CONDITIONS
Brief Title
A Prospective Cohort Study of Myasthenia Gravis in China
Research Team
Y
Yuzhou Guan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
